查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446412

肠溶软胶囊市场：按应用、按分销管道：2023-2032 年全球机会分析和产业预测

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
肠溶软胶囊市场-IMG1

补充品的快速采用营养补充肠溶软胶囊的相关食品有力地推动了肠溶软胶囊市场的成长。随着健康意识的提高，营养补充的需求食品增加，促进营养补充食品的稳定扩张。肠溶衣软胶囊以其精确定制的肠溶衣而着称，已成为一种战略解决方案，可提供精緻的活性成分，同时保护它们免受胃部严酷酸性条件的影响。这种标靶释放机制可优化肠道吸收并提高药物和营养素的生物有效性。肠溶衣软胶囊适合精緻的配方，使其成为旨在有效且高效地提供促进健康的化合物的製造商的首选。

此外，肠溶软胶囊的好处还包括提高患者的依从性，有效减少胃肠道不适的发生。减少副作用的能力提高了补充品和药物的整体耐受性，并促进持续使用。此外，肠溶软胶囊适用于多种配方，使其在製药和营养补充食品中更受欢迎。不断扩大的营养补充食品和肠溶软胶囊的独特优势将无缝协同效应，推动市场成长，而这种成长是由注重健康的消费者不断变化的偏好所驱动，寻求高效且耐受性良好的健康解决方案。它反映了成长。

相关人员的主要利益

  • 该报告提供了细分市场、当前趋势、估计和动态的定量分析，以及 2022 年至 2032 年肠溶衣软胶囊市场分析的动态，并确定了肠溶衣软胶囊市场有前景的市场机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出利润驱动的商业决策并加强供应商-买家网路的潜力。
  • 肠溶软胶囊市场区隔的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场公司定位有助于基准化分析并提供对市场公司当前地位的清晰了解。
  • 该报告包括区域和全球肠溶软胶囊市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可以自订此报告（需要额外的成本和时间表）。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要企业详细资料（Excel 格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章 简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章肠溶软胶囊市场：依应用分类

  • 概述
  • 保健补充品
  • 药品

第五章肠溶软胶囊市场：依分销管道

  • 概述
  • 超级市场和大卖场
  • 药局/药局
  • 线上提供者

第六章肠溶软胶囊市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 巴西
    • 哥伦比亚
    • 阿根廷
    • 其他拉丁美洲
  • 中东/非洲
    • Gcc
    • 南非
    • 北非
    • 其他的

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第八章 公司简介

  • Catalent, Inc.
  • sirio pharma co., ltd.
  • Fuji Capsules Co. Ltd.
  • InovoBiologic Inc
  • NOW Foods Inc.
  • Gelita AG.
  • Captek Softgel International Inc.
  • Viva Pharmaceuticals
  • aenova group
  • Procaps Group
Product Code: A02601
Enteric Softgel Capsules Market - IMG1

The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.

In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.

The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).

The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • Health Supplements
  • Pharmaceuticals

By Distribution Channel

  • Supermarket and Hypermarket
  • Pharmacy and Drug store
  • Online Provider

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest Of La
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Catalent, Inc.
    • sirio pharma co., ltd.
    • Fuji Capsules Co. Ltd.
    • InovoBiologic Inc
    • NOW Foods Inc.
    • Gelita AG.
    • Captek Softgel International Inc.
    • Viva Pharmaceuticals
    • aenova group
    • Procaps Group

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Health Supplements
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Pharmaceuticals
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Supermarket and Hypermarket
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Pharmacy and Drug store
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Online Provider
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Application
    • 6.2.3. Market size and forecast, by Distribution Channel
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Application
      • 6.2.4.1.2. Market size and forecast, by Distribution Channel
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Application
      • 6.2.4.2.2. Market size and forecast, by Distribution Channel
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Application
      • 6.2.4.3.2. Market size and forecast, by Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Application
    • 6.3.3. Market size and forecast, by Distribution Channel
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Application
      • 6.3.4.1.2. Market size and forecast, by Distribution Channel
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Application
      • 6.3.4.2.2. Market size and forecast, by Distribution Channel
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Application
      • 6.3.4.3.2. Market size and forecast, by Distribution Channel
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Market size and forecast, by Application
      • 6.3.4.4.2. Market size and forecast, by Distribution Channel
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Market size and forecast, by Application
      • 6.3.4.5.2. Market size and forecast, by Distribution Channel
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Application
      • 6.3.4.6.2. Market size and forecast, by Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Application
    • 6.4.3. Market size and forecast, by Distribution Channel
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Market size and forecast, by Application
      • 6.4.4.1.2. Market size and forecast, by Distribution Channel
      • 6.4.4.2. China
      • 6.4.4.2.1. Market size and forecast, by Application
      • 6.4.4.2.2. Market size and forecast, by Distribution Channel
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Application
      • 6.4.4.3.2. Market size and forecast, by Distribution Channel
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Market size and forecast, by Application
      • 6.4.4.4.2. Market size and forecast, by Distribution Channel
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Market size and forecast, by Application
      • 6.4.4.5.2. Market size and forecast, by Distribution Channel
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Application
      • 6.4.4.6.2. Market size and forecast, by Distribution Channel
  • 6.5. Latin America
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Application
    • 6.5.3. Market size and forecast, by Distribution Channel
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Application
      • 6.5.4.1.2. Market size and forecast, by Distribution Channel
      • 6.5.4.2. Colombia
      • 6.5.4.2.1. Market size and forecast, by Application
      • 6.5.4.2.2. Market size and forecast, by Distribution Channel
      • 6.5.4.3. Argentina
      • 6.5.4.3.1. Market size and forecast, by Application
      • 6.5.4.3.2. Market size and forecast, by Distribution Channel
      • 6.5.4.4. Rest Of La
      • 6.5.4.4.1. Market size and forecast, by Application
      • 6.5.4.4.2. Market size and forecast, by Distribution Channel
  • 6.6. Middle East and Africa
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by Application
    • 6.6.3. Market size and forecast, by Distribution Channel
    • 6.6.4. Market size and forecast, by country
      • 6.6.4.1. Gcc
      • 6.6.4.1.1. Market size and forecast, by Application
      • 6.6.4.1.2. Market size and forecast, by Distribution Channel
      • 6.6.4.2. South Africa
      • 6.6.4.2.1. Market size and forecast, by Application
      • 6.6.4.2.2. Market size and forecast, by Distribution Channel
      • 6.6.4.3. North Africa
      • 6.6.4.3.1. Market size and forecast, by Application
      • 6.6.4.3.2. Market size and forecast, by Distribution Channel
      • 6.6.4.4. Rest Of Mea
      • 6.6.4.4.1. Market size and forecast, by Application
      • 6.6.4.4.2. Market size and forecast, by Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Catalent, Inc.
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. sirio pharma co., ltd.
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Fuji Capsules Co. Ltd.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. InovoBiologic Inc
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. NOW Foods Inc.
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Gelita AG.
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Captek Softgel International Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Viva Pharmaceuticals
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. aenova group
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Procaps Group
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 02. ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 05. ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 12. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 14. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 25. UK ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. UK ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 27. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 31. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 33. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 38. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 42. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 46. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 48. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 50. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 51. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 53. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 55. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 57. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 59. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 61. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 62. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 66. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 68. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 70. CATALENT, INC.: KEY EXECUTIVES
  • TABLE 71. CATALENT, INC.: COMPANY SNAPSHOT
  • TABLE 72. CATALENT, INC.: PRODUCT SEGMENTS
  • TABLE 73. CATALENT, INC.: SERVICE SEGMENTS
  • TABLE 74. CATALENT, INC.: PRODUCT PORTFOLIO
  • TABLE 75. CATALENT, INC.: KEY STRATERGIES
  • TABLE 76. SIRIO PHARMA CO., LTD.: KEY EXECUTIVES
  • TABLE 77. SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 78. SIRIO PHARMA CO., LTD.: PRODUCT SEGMENTS
  • TABLE 79. SIRIO PHARMA CO., LTD.: SERVICE SEGMENTS
  • TABLE 80. SIRIO PHARMA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 81. SIRIO PHARMA CO., LTD.: KEY STRATERGIES
  • TABLE 82. FUJI CAPSULES CO. LTD.: KEY EXECUTIVES
  • TABLE 83. FUJI CAPSULES CO. LTD.: COMPANY SNAPSHOT
  • TABLE 84. FUJI CAPSULES CO. LTD.: PRODUCT SEGMENTS
  • TABLE 85. FUJI CAPSULES CO. LTD.: SERVICE SEGMENTS
  • TABLE 86. FUJI CAPSULES CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 87. FUJI CAPSULES CO. LTD.: KEY STRATERGIES
  • TABLE 88. INOVOBIOLOGIC INC: KEY EXECUTIVES
  • TABLE 89. INOVOBIOLOGIC INC: COMPANY SNAPSHOT
  • TABLE 90. INOVOBIOLOGIC INC: PRODUCT SEGMENTS
  • TABLE 91. INOVOBIOLOGIC INC: SERVICE SEGMENTS
  • TABLE 92. INOVOBIOLOGIC INC: PRODUCT PORTFOLIO
  • TABLE 93. INOVOBIOLOGIC INC: KEY STRATERGIES
  • TABLE 94. NOW FOODS INC.: KEY EXECUTIVES
  • TABLE 95. NOW FOODS INC.: COMPANY SNAPSHOT
  • TABLE 96. NOW FOODS INC.: PRODUCT SEGMENTS
  • TABLE 97. NOW FOODS INC.: SERVICE SEGMENTS
  • TABLE 98. NOW FOODS INC.: PRODUCT PORTFOLIO
  • TABLE 99. NOW FOODS INC.: KEY STRATERGIES
  • TABLE 100. GELITA AG.: KEY EXECUTIVES
  • TABLE 101. GELITA AG.: COMPANY SNAPSHOT
  • TABLE 102. GELITA AG.: PRODUCT SEGMENTS
  • TABLE 103. GELITA AG.: SERVICE SEGMENTS
  • TABLE 104. GELITA AG.: PRODUCT PORTFOLIO
  • TABLE 105. GELITA AG.: KEY STRATERGIES
  • TABLE 106. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 107. CAPTEK SOFTGEL INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 108. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 109. CAPTEK SOFTGEL INTERNATIONAL INC.: SERVICE SEGMENTS
  • TABLE 110. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 111. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 112. VIVA PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 113. VIVA PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 114. VIVA PHARMACEUTICALS: PRODUCT SEGMENTS
  • TABLE 115. VIVA PHARMACEUTICALS: SERVICE SEGMENTS
  • TABLE 116. VIVA PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 117. VIVA PHARMACEUTICALS: KEY STRATERGIES
  • TABLE 118. AENOVA GROUP: KEY EXECUTIVES
  • TABLE 119. AENOVA GROUP: COMPANY SNAPSHOT
  • TABLE 120. AENOVA GROUP: PRODUCT SEGMENTS
  • TABLE 121. AENOVA GROUP: SERVICE SEGMENTS
  • TABLE 122. AENOVA GROUP: PRODUCT PORTFOLIO
  • TABLE 123. AENOVA GROUP: KEY STRATERGIES
  • TABLE 124. PROCAPS GROUP: KEY EXECUTIVES
  • TABLE 125. PROCAPS GROUP: COMPANY SNAPSHOT
  • TABLE 126. PROCAPS GROUP: PRODUCT SEGMENTS
  • TABLE 127. PROCAPS GROUP: SERVICE SEGMENTS
  • TABLE 128. PROCAPS GROUP: PRODUCT PORTFOLIO
  • TABLE 129. PROCAPS GROUP: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ENTERIC SOFTGEL CAPSULES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ENTERIC SOFTGEL CAPSULES MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN ENTERIC SOFTGEL CAPSULES MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. ENTERIC SOFTGEL CAPSULES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 19. U.S. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 20. CANADA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. UK ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. ITALY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CHINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. INDIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. GCC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: ENTERIC SOFTGEL CAPSULES MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2022